Use of QuantiFERON®-TB Gold to investigate tuberculosis contacts in a high school

Respirology

Volumn 12, Issue 1, 2007, Pages 88-92

  Higuchi, Kazue ^a   Harada, Nobuyuki ^a   Mori, Toru ^a,b   Sekiya, Yukie ^a,c  

^a RESEARCH INSTITUTE OF TUBERCULOSIS   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c KITASATO UNIVERSITY   (Japan)

Author keywords

Chemoprophylaxis; Contact investigation; High school; QuantiFERON TB Gold; Tuberculin skin test

Indexed keywords

BCG VACCINE; GOLD; ISONIAZID; TUBERCULIN; DIAGNOSTIC AGENT;

ADOLESCENT; ARTICLE; BCG VACCINATION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; FOLLOW UP; HUMAN; INFECTION PREVENTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; RISK ASSESSMENT; SCREENING TEST; THORAX RADIOGRAPHY; TUBERCULIN TEST; TUBERCULOSIS; EPIDEMIC; JAPAN; MASS SCREENING; METHODOLOGY; RETROSPECTIVE STUDY; SCHOOL; STATISTICS; STUDENT;

ADOLESCENT; DISEASE OUTBREAKS; HUMANS; JAPAN; MALE; MASS SCREENING; RETROSPECTIVE STUDIES; SCHOOLS; STUDENTS; TUBERCULIN; TUBERCULIN TEST; TUBERCULOSIS;

EID: 33845692422     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2006.01000.x     Document Type: Article

References (25)

1. Ministry of Health, Labor and Welfare (ed.). Statistics of Tuberculosis 2005. Japanese Anti-Tuberculosis Association, Tokyo, Japan, 2005. (in Japanese).
2. Huebner RE, Schein MF, Bass JB Jr. The tuberculin skin test. Clin. Infect. Dis. 1993; 17: 968-75.
3. Andersen P, Munk ME, Pollock JM, Doherty TM. Specific immune-based diagnosis of tuberculosis. Lancet 2000; 356: 1099-104.
4. Mori T, Sakatani M, Yamagishi F et al. Specific detection of tuberculosis infection with an interferon-gamma based assay using new antigens. Am. J. Respir. Crit. Care Med. 2004; 170: 59-64.
5. Harada N, Mori T, Shishido S, Higuchi K, Sekiya Y. Usefulness of a novel diagnostic method of tuberculosis infection, QuantiFERON®TB-2G, in an outbreak of tuberculosis. Kekkaku 2004; 79: 637-43. (In Japanese with English abstract, tables and figures.)
6. Brock I, Weldingh K, Lillebaek T, Follmann F, Andersen P. Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts. Am. J. Respir. Crit. Care Med. 2004; 170: 65-9.
7. Funayama K, Tsujimoto A, Mori M et al. Usefulness of QuantiFERON TB-2G in contact investigation of a tuberculosis outbreak in a University. Kekkaku 2005; 80: 527-34. (In Japanese with English abstract, tables and figures.)
8. Harada N, Nakajima Y, Higuchi K, Sekiya Y, Rothel J, Mori T. Screening for tuberculosis infection using whole-blood interferon-gamma and Mantoux testing among Japanese healthcare workers. Infect. Control Hosp. Epidemiol. 2006; 27: 442-8.
9. Kang YA, Lee HW, Yoon HI et al. Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA 2005; 293: 2756-61.
10. Pai M, Gokhale K, Joshi R et al. Mycobacterium tuberculosis infection in health care workers in rural India: comparison of a whole-blood interferon gamma assay with tuberculin skin testing. JAMA 2005; 293: 2746-55.
11. Diel R, Nienhaus A, Lange C, Meywald-Walter K, Forssbohm M, Schaberg T. Tuberculosis contact investigation with a new, specific blood test in a low-incidence population containing a high proportion of BCG-vaccinated persons. Respir. Res. 2006; 7: 77-85.
12. Maeda M, Asami N, Murohashi T. Further studies on the potency of purified protein derivatives of tuberculin (PPD-s). 1st Report. Comparison of the potency of three preparations of PPD. Kekkaku 1960; 35: 563-6. (In Japanese.)
13. Kimura M, Comstock GL, Mori T. Comparison of erythema and induration as results of tuberculin tests. Int. J. Tuberc. Lung Dis. 2005; 9: 853-7.
14. Ewer K, Deeks J, Alvarez L et al. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 2003; 361: 1168-73.
15. Richeldi L, Ewer K, Losi M et al. Early diagnosis of subclinical multidrug-resistant tuberculosis. Ann. Intern. Med. 2004; 140: 709-13.
16. Ferebee SH. Controlled chemoproplylaxis trial in tuberculosis. A general review. Bibl. Tuberc. 1970; 26: 28-106.
17. IUAT. Efficacy of various duration of isoniazid preventive therapy for tuberculosis: five years follow-up in the IUAT trial. Bull. WHO 1982; 60: 555-64.
18. ATS/CDC Statement Committee on Latent Tuberculosis Infection. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Recomm. Rep. 2000; 49: 1-51.
19. Karalliedde S, Katugaha LP, Uragoda CG. Tuberculin response of Sri Lankan children after BCG vaccination at birth. Tubercle 1987; 68: 33-8.
20. Menzies R, Vissandjee B, Rocher I, St Germain Y. The booster effect in two-step tuberculin testing among young adults in Montreal. Ann. Intern. Med. 1994; 120: 190-8.
21. Mori T. A present state and control of tuberculosis. Intern. Med. 2001; 90: 111-15. (In Japanese.)
22. Diel R, Nienhaus A, Lange C, Schaberg T. Cost-optimisation of screening for latent tuberculosis in close contacts. Eur. Respir. J. 2006; 28: 35-44.
23. Mori T, Harada N. Cost-effectiveness analysis of QuantiFERON-TB 2nd generation used for detection of tuberculosis infection in contact investigations. Kekkaku 2005; 80: 675-86. (In Japanese with English abstract, tables and figures.)
24. National Institute for Clinical Excellence (NICE). TUBERCULOSIS. Clinical diagnosis and management of tuberculosis, and measures for its prevention and control. [Cited March 2006.] Available from: http://www.nice.org.uk/page.aspx?o= CG033
25. Richeldi L, Ewer K, Losi M et al. Repeated tuberculin testing does not induce false positive ELISPOT results. Thorax 2006; 61: 180.